1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Excessive Daytime Sleepiness: new trials by email Literature Review of Excessive Daytime Sleepiness trials Research Report on Excessive Daytime Sleepiness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study Solriamfetol, Placebo - Excessive Daytime Sleepiness, Obstructive Sleep Apnea | Phase 4 | Completed | Axsome Therapeutics, Inc. | 59 | 2021-05-17 | 2026-01-26 |
Disorders of Excessive Somnolence (1) · Sleep Apnea, Obstructive (1)
Apnea (1) · Dyssomnias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Sleep Apnea Syndromes (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
solriamfetol (1)
Canada (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)